DPT-Hib vaccine

Last updated
DPT-Hib vaccine
Combination of
Diphtheria vaccine Vaccine
Tetanus vaccine Vaccine
Pertussis vaccine Vaccine
Hib vaccine Vaccine
Clinical data
Trade names Tetramune
AHFS/Drugs.com Micromedex Detailed Consumer Information
Routes of
administration
Intramuscular injection
ATC code

DPT-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis vaccine adsorbed with Hib conjugate vaccine, sometimes abbreviated to DPT-Hib. [1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B. [1]

A branded formulation was marketed in the US as Tetramune by Lederle Praxis Biologicals (subsequently acquired by Wyeth). [2] Tetramune has since been discontinued. [3] [4]

References

  1. 1 2 "Diphtheria and Tetanus Toxoids and Pertussis Vaccine Adsorbed and Haemophilus B Conjugate Vaccine (Systemic)". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
  2. Centers for Disease Control Prevention (CDC) (April 1993). "FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children". MMWR. Morbidity and Mortality Weekly Report. 42 (15). Centers for Disease Control and Prevention: 296–8. PMID   8479415 . Retrieved 15 July 2018.
  3. "Selected Discontinued U.S. Vaccines" (PDF). Centers for Disease Control and Prevention . Retrieved 15 July 2018.
  4. Zarei AE, Almehdar HA, Redwan EM (2016). "Hib Vaccines: Past, Present, and Future Perspectives". Journal of Immunology Research. 2016 7203587. doi: 10.1155/2016/7203587 . PMC   4745871 . PMID   26904695. Table 1